| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
47,360,000 as of 7/31 |
| Market
Cap: |
5.07(B) |
| Last
Volume: |
371,327 |
Avg
Vol: |
503,171 |
| 52
Week Range: |
$72.29 - $116 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 315 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile The Cooper Companies is a medical device company. Co. operates through two business units, CooperVision, Inc. (CooperVision) and CooperSurgical, Inc. (CooperSurgical). CooperVision is a manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products support the point of healthcare delivery in the hospital, clinicians office and fertility clinics.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
256,941 |
341,379 |
728,785 |
1,432,753 |
| Total Sell Value |
$27,293,171 |
$35,082,737 |
$71,575,619 |
$126,050,978 |
| Total People Sold |
9 |
11 |
14 |
16 |
| Total Sell Transactions |
11 |
17 |
39 |
79 |
| End Date |
2013-02-21 |
2012-11-20 |
2012-05-22 |
2011-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Remmell Paul L |
Pres & CEO - CSI |
|
2013-04-11 |
4 |
OE |
$13.10 |
$140,951 |
D/D |
10,725 |
19,646 |
|
- |
|
Bender A Thomas |
Director |
|
2013-04-11 |
4 |
S |
$108.04 |
$540,200 |
D/D |
(5,000) |
31,944 |
|
2% |
|
Remmell Paul L |
Pres & CEO - CSI |
|
2013-04-11 |
4 |
S |
$108.83 |
$1,685,559 |
D/D |
(15,488) |
4,158 |
|
2% |
|
Press Donald |
Director |
|
2013-04-10 |
4 |
S |
$108.07 |
$810,525 |
D/D |
(7,500) |
42,926 |
|
1% |
|
Press Donald |
Director |
|
2013-04-10 |
4 |
OE |
$69.39 |
$520,425 |
D/D |
7,500 |
50,426 |
|
- |
|
Weber John Arthur |
President, CooperVision, Inc. |
|
2013-04-05 |
4 |
S |
$107.19 |
$2,497,956 |
D/D |
(23,304) |
11,995 |
|
-1% |
|
Weber John Arthur |
President, CooperVision, Inc. |
|
2013-04-05 |
4 |
OE |
$67.65 |
$1,576,516 |
D/D |
23,304 |
35,299 |
|
- |
|
Folden Rodney |
VP & Corporate Controller |
|
2013-04-03 |
4 |
OE |
$67.65 |
$1,353,000 |
D/D |
20,000 |
26,682 |
|
- |
|
Folden Rodney |
VP & Corporate Controller |
|
2013-04-03 |
4 |
S |
$107.02 |
$2,140,400 |
D/D |
(20,000) |
6,682 |
|
-0% |
|
Mcbride Daniel G |
VP, General Counsel & CRO |
|
2013-03-28 |
4 |
S |
$107.50 |
$2,257,582 |
D/D |
(21,000) |
13,944 |
|
1% |
|
Mcbride Daniel G |
VP, General Counsel & CRO |
|
2013-03-28 |
4 |
OE |
$13.10 |
$276,750 |
D/D |
21,000 |
19,944 |
|
- |
|
Press Donald |
Director |
|
2013-03-28 |
4 |
S |
$107.50 |
$1,075,000 |
D/D |
(10,000) |
42,926 |
|
1% |
|
Press Donald |
Director |
|
2013-03-28 |
4 |
OE |
$69.39 |
$693,900 |
D/D |
10,000 |
52,926 |
|
- |
|
Pichotta Nicholas J |
Pres, CEO Cooper Medical, Inc. |
|
2013-03-27 |
4 |
OE |
$13.10 |
$140,951 |
D/D |
10,725 |
20,326 |
|
- |
|
Pichotta Nicholas J |
Pres, CEO Cooper Medical, Inc. |
|
2013-03-27 |
4 |
S |
$105.50 |
$1,591,784 |
D/D |
(15,088) |
9,363 |
|
-0% |
|
Weber John Arthur |
President, CooperVision, Inc. |
|
2013-03-26 |
4 |
S |
$104.28 |
$632,041 |
D/D |
(6,061) |
11,995 |
|
-2% |
|
Weiss Robert S |
President and CEO |
|
2013-03-12 |
4 |
S |
$105.11 |
$5,576,020 |
D/D |
(53,000) |
119,428 |
|
-2% |
|
Weiss Robert S |
President and CEO |
|
2013-03-12 |
4 |
OE |
$13.21 |
$700,130 |
D/D |
53,000 |
172,428 |
|
- |
|
Kaufman Carol R |
Secretary, EVP, & CAO |
|
2013-03-12 |
4 |
S |
$105.37 |
$8,486,104 |
D/D |
(80,500) |
27,291 |
|
-2% |
|
Kaufman Carol R |
Secretary, EVP, & CAO |
|
2013-03-12 |
4 |
OE |
$35.69 |
$3,077,170 |
D/D |
80,500 |
107,791 |
|
- |
|
Petersmeyer Gary S |
Director |
|
2013-02-04 |
4 |
A |
$0.10 |
$125 |
D/D |
1,250 |
1,250 |
|
- |
|
Mcbride Daniel G |
VP, General Counsel & CRO |
|
2013-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,950 |
16,527 |
|
- |
|
Mcbride Daniel G |
VP, General Counsel & CRO |
|
2013-02-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,583) |
13,944 |
|
- |
|
Kaufman Carol R |
Secretary, EVP, & CAO |
|
2013-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,750 |
30,814 |
|
- |
|
Kaufman Carol R |
Secretary, EVP, & CAO |
|
2013-02-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,523) |
27,291 |
|
- |
|
797 Records found
|
|
Page 1 of 32 |
|
|